v3.24.3
Cash Equivalents and Marketable Securities
 9 Months Ended
Sep. 30, 2024
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable Securities
Cash equivalents and marketable securities consisted of the following at September 30, 2024 (in thousands):
Amortized
Cost		Allowance
for Credit
Losses		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Fair
Value
Cash equivalents and marketable securities:
Government agency securities$13,999 $— $— $(26)$13,973 
U.S. Treasuries148,228 — 553 — 148,781 
Money market funds95,832 — — — 95,832 
Corporate notes/bonds6,507 — — (5)6,502 
Total $264,566 $— $553 $(31)$265,088 
Cash equivalents and marketable securities consisted of the following at December 31, 2023 (in thousands):
Amortized
Cost		Allowance
for Credit
Losses		Gross
Unrealized
Gains		Gross
Unrealized
Losses		Fair
Value
Cash equivalents and marketable securities:
Government agency securities$103,507 $— $— $(327)$103,180 
Money market funds123,652 — — — 123,652 
Corporate notes/bonds30,920 — — (86)30,834 
U.S. Treasuries168,858 — 611 — 169,469 
Total$426,937 $— $611 $(413)$427,135 
As of September 30, 2024, the Company held three marketable securities that were in a continuous unrealized loss position that amounted to $2.0 thousand. The Company neither intends to sell these marketable securities, nor does it believe that it is more-likely-than-not to conclude that the Company will have to sell the securities before recovery of their carrying values. The Company also believes that it will be able to collect, in full, both principal and interest amounts due at maturity. Furthermore, the Company has determined that there were no material changes in the credit risk of the securities. As of September 30, 2024, the Company holds no securities with remaining maturities greater than one year.
There were no realized gains or losses on available-for-sale securities during the nine months ended September 30, 2024 or 2023.